Targeted therapies and resistance mechanisms in lymphoma: Current landscape and emerging solutions (IMAGE)
Caption
Figure 2: Key resistance mechanisms to targeted therapy (antigen loss, pathway reactivation, microenvironmental immune suppression).
Credit
Copyright: © 2025 Tiwari et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Usage Restrictions
With credit to the original source.
License
Original content